| Nov 19 |
Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode
|
| Nov 19 |
Pfizer, Arvinas delay late-stage trial for breast cancer therapy
|
| Nov 4 |
Arvinas to Participate in Upcoming Investor Conferences
|
| Nov 1 |
Arvinas Third Quarter 2024 Earnings: Beats Expectations
|
| Oct 31 |
Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ...
|
| Oct 30 |
Arvinas, Inc. (ARVN) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates
|
| Oct 30 |
Arvinas GAAP EPS of -$0.68 beats by $0.13, revenue of $102.4M beats by $40M
|
| Oct 30 |
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Oct 29 |
Arvinas Q3 2024 Earnings Preview
|
